Prevalence of Thyroid Dysfunction and Anti-thyroid Antibodies in Infertile Women
24. maj 2019 opdateret af: Ahmed M Maged, MD, Cairo University
The study population will be divided into three groups:
- Group (A) consisting of 40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility,
- Group (B) consisting of 40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility, and
Group (C) consisting of 40 women with exclusive male factor of infertility and will be used as a control group.
. All women will be subjected to:
- Informed consent
- Full history taking, including age, duration of infertility and whether primary or secondary
- General and pelvix examination
- Trans-vaginal ultrasonography
- Determination of hormonal profile (FSH, LH, Estradiol, Prolactin)
- Determination of ovulatory status
- Determination of of tubal patency
- Determination of presence of male factor
- Determination of TSH and antithyroid antibodies (antithyroglobulin and antithyroid peroxidase) blood levels
Studieoversigt
Status
Ukendt
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The study population will be divided into three groups:
- Group (A) consisting of 40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility,
- Group (B) consisting of 40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility, and
Group (C) consisting of 40 women with exclusive male factor of infertility and will be used as a control group.
. All women will be subjected to:
- Informed consent
- Full history taking, including age, duration of infertility and whether primary or secondary
- General and pelvix examination
- Trans-vaginal ultrasonography
- Determination of hormonal profile (FSH, LH, Estradiol, Prolactin)
- Determination of ovulatory status (by previous documented history of induction of ovulation OR previous ultrasonography OR previous estimation midluteal serum progesterone, etc …)
- Determination of of tubal patency (by previous hysterosalpingiography or laparoscopy)
- Determination of presence of male factor (by seminal fluid analysis)
- Determination of TSH and antithyroid antibodies (antithyroglobulin and antithyroid peroxidase) blood levels
Undersøgelsestype
Observationel
Tilmelding (Forventet)
120
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Cairo, Egypten, 12151
- Kasr Alainy medical school
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
20 år til 40 år (Voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Kvinde
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
120 women with infertility will be divided into three groups:
- Group (A) consisting of 40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility,
- Group (B) consisting of 40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility, and
- Group (C) consisting of 40 women with exclusive male factor of infertility and will be used as a control group.
Beskrivelse
Inclusion Criteria:
- - Age: 18 - 38 years
- Infertile women whether due to functional, anatomical, male factors OR unexplained OR combined factors
Exclusion Criteria:
- - Age: below 18 and above 38 years
- Patients with autoimmune diseases (such as lupus and rheumatoid arthritis)
- Acute illness that require hospitalization
- Patients on the following medications: steroids, dopamine, iodine, amiodarone, lithium, donperidone, thyroid hormone, and phenytoin.
- Patients who work at night.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Case-Control
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Anovulatory women
40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility
|
Measurement of Thyroid stimulating hormone
Andre navne:
antithyroglobulin and antithyroid peroxidase
Andre navne:
|
|
Tubal factor women
40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility
|
Measurement of Thyroid stimulating hormone
Andre navne:
antithyroglobulin and antithyroid peroxidase
Andre navne:
|
|
male factor couple
40 women with exclusive male factor of infertility and will be used as a control group
|
Measurement of Thyroid stimulating hormone
Andre navne:
antithyroglobulin and antithyroid peroxidase
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
prevalence of thyroid dysfunction among infertile women
Tidsramme: through study completion, an average of 6 months
|
prevalence of thyroid dysfunction (clinical or subclinical, hypothyroidism or hyperthyroidism) among infertile women
|
through study completion, an average of 6 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Forventet)
1. maj 2019
Primær færdiggørelse (Forventet)
1. december 2019
Studieafslutning (Forventet)
1. januar 2020
Datoer for studieregistrering
Først indsendt
23. maj 2019
Først indsendt, der opfyldte QC-kriterier
24. maj 2019
Først opslået (Faktiske)
28. maj 2019
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
28. maj 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
24. maj 2019
Sidst verificeret
1. maj 2019
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 57
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Uafklaret
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .